Altimmune
ALT
ALT
112 hedge funds and large institutions have $79.2M invested in Altimmune in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 40 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 40
36% less capital invested
Capital invested by funds: $125M → $79.2M (-$45.3M)
Holders
112
Holding in Top 10
–
Calls
$2.13M
Puts
$898K
Top Buyers
| 1 | +$866K | |
| 2 | +$701K | |
| 3 | +$645K | |
| 4 |
D.E. Shaw & Co
New York
|
+$589K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$533K |
Top Sellers
| 1 | -$2.68M | |
| 2 | -$2.2M | |
| 3 | -$1.9M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.76M |
| 5 |
Morgan Stanley
New York
|
-$1.55M |